From Awareness to Action on Global Fatty Liver Day

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and […]

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments

WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and treatment of fatty liver disease to prevent its progression to chronic liver disease, cirrhosis, or cancer.

Fatty liver disease is now estimated to affect 1 in 3 adults worldwide, and its prevalence is increasing. Fatty liver disease during childhood, once unheard of, is also on the rise. Early detection and timely intervention, whether through lifestyle changes or medical treatments, are essential in stopping and even reversing the progression of the disease. “Act Now, Screen Today” emphasizes that liver health is achievable, but action must begin immediately. Across the globe, partners are driving awareness and educational efforts and ensuring broader access to essential screenings and care.

Global Fatty Liver Day, observed annually on the second Thursday of June, is a rallying cry for collective action to address the growing prevalence of fatty liver disease, the most common liver disease worldwide. “Act Now, Screen Today” reminds everyone that liver health is within reach. Here are specific actions you can take today:

  • Take advantage of liver health screening events happening globally to get assessed for fatty liver disease or schedule a check-up with your doctor, especially if you are managing closely associated metabolic conditions like obesity or diabetes
  • Increase physical activity, as maintaining an active lifestyle can improve liver health
  • Learn about fatty liver disease and its risk factors to take proactive steps towards prevention and management yourself or learn more about the latest research and guidelines for your patients.

With a robust pipeline of pharmaceutical treatments that address diverse mechanisms of action in progress, it is important to identify individuals’ position within the progression of fatty liver disease so that they are poised to receive the most appropriate care possible. Notably, pharmaceutical treatments are available (for certain groups with advanced disease) in two countries, the United States (resmetirom) and India (saroglitazar).

“As a community, we stand at a critical time for the broader global health system to act now to support patients,” shares Donna R. Cryer, JD, Founder and CEO of GLI. “As pharmaceutical treatment options gain approval in different geographies, health payers and systems must listen to the call from global advocates and not place undue obstacles to care – whether that be required biopsy, ambiguous lifestyle requirements, or other hurdles – so that patients are able to access the care they require, no matter who or where they are.”

Recognizing the importance of early detection, a diverse range of partners, including healthcare providers, patient advocacy groups, and community organizations, have joined forces to “Act Now, Screen Today” and launch screening events around the world. From Chile to Nigeria to the Netherlands, the Philippines, and beyond, these events aim to raise awareness, provide education, and offer screening services to individuals at risk of fatty liver disease or the providers who care for them. Global Fatty Liver Day activities are driving positive change at the grassroots level.

“Global Fatty Liver Day is an urgent call-to-action to unite our global efforts to confront the scourge of fatty liver disease,” shares Cat Evans, Director of Program Operations at GLI. “We must act now. By working together, we have the power to create significant change in preventing and managing this pressing health issue through our collaborative efforts.”

Although the challenge of fatty liver disease to the well-being of communities around the globe is great, the power of locally-rooted, collective efforts can turn the tide towards positive change by heightening awareness, equipping people and their healthcare providers with prevention and management tools, expanding understanding of the disease through research, and protecting future liver health through effective policies.

About Global Liver Institute

Global Liver Institute (GLI) is a 501(c)3 nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness. GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease. Follow GLI on FacebookInstagramLinkedIn, and YouTube, or visit www.globalliver.org. GLI is the host of Global Fatty Liver Day.

Christine Maalouf
Global Liver Institute
cmaalouf@globalliver.org

GlobeNewswire Distribution ID 9153607

Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

ADALVO LIMITED Anil Okay, Adalvo CEO, expresses his thoughts on this milestone SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza® pre-filled pen, indicated for the treatment of type 2 […]

ADALVO LIMITED
Anil Okay, Adalvo CEO, expresses his thoughts on this milestone

SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.

As a bioequivalent version of Victoza® pre-filled pen, indicated for the treatment of type 2 diabetes, this peptide drug achieved global sales exceeding $4.8 billion in 2023, as reported by IQVIA.

The successful development of Liraglutide highlights Adalvo’s capability to offer a diverse and comprehensive diabetes portfolio, encompassing both complex peptide injectables and small molecule oral treatments.

Adalvo’s commitment to providing access to high-quality differentiated products while simultaneously navigating manufacturing complexities reinforces Adalvo’s position as a trusted leader in the pharmaceutical industry.

Click Here To View Adalvo’s Diabetes Portfolio

At Adalvo, there are no half-measures – they are always on target. Their mission is to be faster and stronger than their competitors, driving their vision forward with a winning team.

Adalvo is committed to maintaining the highest standards of excellence in all their endeavors and looks forward to continuing to deliver innovative healthcare solutions that make a difference in the lives of patients worldwide.

About Adalvo

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 130 countries and over 140 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering the highest quality differentiated products and services to our partners.

Adalvo takes pride in their ability to help partners reach their goals – be those increasing revenues or pushing into new markets. Tirelessly strives for excellence in all of its endeavours, driven by a deep-rooted passion for making a difference for partners.

The company’s purpose-driven culture is committed to improving the lives of patients around the world. Adalvo’s dynamic leadership team brings significant experience and industry know-how, which has helped to establish the company as a reliable global partner in the industry.

Contacts: Gabrielle Cassar, gabrielle.cassar@adalvo.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e1e895aa-f689-4215-a1f8-25285851af9d

GlobeNewswire Distribution ID 1000966220

Nikkiso Clean Energy & Industrial Gases Group Announces CEO Transition July 1, 2024

TEMECULA, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE: 6376), announced today after a Board vote, that effective July 1, 2024, Adrian Ridge will succeed Peter Wagner as Nikkiso Clean Energy & Industrial Gases Group’s (part of Nikkiso’s Industrial Division) as Chief Executive Officer. Wagner will stay on in a Board role […]

TEMECULA, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE: 6376), announced today after a Board vote, that effective July 1, 2024, Adrian Ridge will succeed Peter Wagner as Nikkiso Clean Energy & Industrial Gases Group’s (part of Nikkiso’s Industrial Division) as Chief Executive Officer. Wagner will stay on in a Board role as Executive Chairman for Nikkiso CE&IG Group.

As CEO, Ridge, who is currently Executive Vice President, Operations and Manufacturing for Nikkiso CE&IG Group, will drive operational and financial results and ready the Group for future growth. Wagner’s new role as Executive Chairman will focus on driving the vision and long-term strategy of the Group in an advisor capacity.

“In six years under Peter’s leadership, Nikkiso CE&IG has more than quadrupled business, and is positioned for strong continued growth,” said Toshihiko Kai, President and CEO, Nikkiso. “I want to thank him for his leadership, and welcome Adrian as the Group’s new CEO.”

Prior to joining Nikkiso in 2018, Wagner was CEO and Managing Director at LEWA Group. Ridge joined Nikkiso in 2022 after approximately 30 years at Atlas Copco serving in various leadership positions.

About Nikkiso Co. Ltd.

Since its establishment in 1953, Nikkiso has contributed to solving social issues by anticipating the changing times with world-first and Japan-first technologies and products. In the industrial business, Nikkiso has created new markets by developing products in the energy field, hemodialysis-related products in the medical business, and CFRP (carbon fiber reinforced plastic) aerostructures in the aerospace business.

About Nikkiso Clean Energy & Industrial Gases Group

The Nikkiso Clean Energy & Industrial Gases Group is a leading provider of cryogenic equipment, technologies and applications for clean energy and industrial gas market segments. The Group employs more than 1,600 people in 22 countries and is headed by Cryogenic Industries, Inc. in Southern California, U.S., which is a wholly owned subsidiary of Nikkiso Co., Ltd. (TSE: 6376).

Media contact
Lisa Adams
+1 405 492 1689

GlobeNewswire Distribution ID 9153273

President for prompt relief to aggrieved insurance policyholders

President Asif Ali Zardari has directed Federal Insurance Ombudsman to provide speedy and cost-free justice to aggrieved insurance policy holders against maladministration of insurance companies.

Talking to newly-appointed Federal Insurance Ombudsman…

President Asif Ali Zardari has directed Federal Insurance Ombudsman to provide speedy and cost-free justice to aggrieved insurance policy holders against maladministration of insurance companies. Talking to newly-appointed Federal Insurance Ombudsman Mumtaz Ali Shah in Islamabad today, he stressed Federal Insurance Office to enhance its outreach and ensure quick disposal of complaints to provide monetary relief to maximum number of citizens. The President highlighted the need to create awareness about the role of Federal Insurance Office in providing justice to aggrieved policyholders in the settlement of insurance claims. The President also advised the Federal Insurance Office to use modern technology tools to increase disposal of the complaints. Source: Radio Pakistan

PM approves initiation of legislation regarding Ease of Doing Business Act

Prime Minister Shehbaz Sharif has approved the initiation of legislation regarding the Ease of Doing Business Act.

The Prime Minister granted the approval while chairing an important review meeting on measures regarding ease of doing business and inv…

Prime Minister Shehbaz Sharif has approved the initiation of legislation regarding the Ease of Doing Business Act. The Prime Minister granted the approval while chairing an important review meeting on measures regarding ease of doing business and investment, in Islamabad today. Speaking on the occasion, the Prime Minister said promotion of business and investor friendly environment in Pakistan is the top priority of the government. The Prime Minister said documentation procedures should be simplified for business and business community under one window operations. In this regard, he directed to obtain assistance from Chinese experts regarding the establishment of one-stop shop facility center on the pattern of established project in Shenzhen, China. The meeting was briefed on Ease of Doing Business and other initiatives. It was informed that an electronic registry will be set up for business registration, licenses certificates and other documents. The forum was apprised that an online One Window Pakist an Business Portal system will be introduced through which the services of all relevant institutions will be available at one place. Source: Radio Pakistan

Pakistan urges global action for immediate ceasefire in Gaza

Pakistan says time has come to hold Israel accountable for its grave crimes, urging the global conscience to force Israel towards immediate and unconditional ceasefire in Gaza.

At her weekly media briefing in Islamabad today, Foreign Office Spokesper…

Pakistan says time has come to hold Israel accountable for its grave crimes, urging the global conscience to force Israel towards immediate and unconditional ceasefire in Gaza. At her weekly media briefing in Islamabad today, Foreign Office Spokesperson, Mumtaz Zahra Baloch said it is also critical to bring an end to the war on people of Palestine. She said Pakistan also welcomes the report of the United Nations Independent International Commission of Inquiry on Occupied Palestinian territory including East Jerusalem and Israel. The Spokesperson said the findings of the Commission of Inquiry have confirmed reports of the Israeli war crimes of starvation as a method of warfare, murder or willful killing, intentionally directing attacks against civilians, forcible transfer, torture and inhuman and cruel punishment. Turning to situation in Indian Illegally Occupied Jammu and Kashmir, Mumtaz Zahra Baloch said Pakistan remembers the victims of the massacre at Chota Bazaar, Srinagar in 1991. She said the 33rd anniversary of the massacre was observed on Tuesday last in which India's Central Reserve Force personnel opened fire at civilians, resulted in killing of thirty-two civilians and injuring twenty-two others. The Spokesperson reiterated that Pakistan will continue to extend political, diplomatic, and moral support to our Kashmiri brothers and sisters for the just and peaceful settlement of the Jammu and Kashmir dispute in accordance with the UN Security Council resolutions. Replying to a question, she said Pakistan and Afghanistan have been engaged to discuss all aspects of trade mechanism. She said the two have agreed to implement these arrangements to facilitate trade vehicles, drivers and helpers from both sides. Source: Radio Pakistan

Minister for Power outlines reforms plan for power sector

Minister for Power Sardar Awais Leghari says Pakistan is starting a fan replacement program that will save energy and improve the seasonal variation in energy demand.

Talking to the delegation of the US Department of Treasury in Islamabad today, he s…

Minister for Power Sardar Awais Leghari says Pakistan is starting a fan replacement program that will save energy and improve the seasonal variation in energy demand. Talking to the delegation of the US Department of Treasury in Islamabad today, he said that the reform plan has been made to remove the deficiencies in the power sector. He said that the reform plan has been made to remove the deficiencies in the power sector and its purpose is to improve the energy mix of country and eliminate other deficiencies of the power sector. The Minister said that reforms are being implemented to increase private sector participation in the distribution and transmission of electricity in the country. These reforms aim to improve the quality of service being delivered to the people of Pakistan. Sardar Awais Leghari expressed the need for U.S. technical support to address the seasonal generation and demand gap and also highlighted the importance of American assistance in securing international financing for Pakistan' s power sector at more favorable rates. The US Assistant Secretary of Treasury appreciated Pakistan's power sector reform initiatives and assured all possible cooperation to resolve Pakistan's power sector problems. Source: Radio Pakistan

Deputy PM felicitates Irfan Siddiqui on his election as SFAC chairman

Deputy Prime Minister, Foreign Minister and Leader of the House in Senate, Senator Ishaq Dar has extended heartfelt congratulations to Senator Irfan Siddiqui on his unopposed election as Chairman of the Senate Foreign Affairs Committee.

In his messag…

Deputy Prime Minister, Foreign Minister and Leader of the House in Senate, Senator Ishaq Dar has extended heartfelt congratulations to Senator Irfan Siddiqui on his unopposed election as Chairman of the Senate Foreign Affairs Committee. In his message, he emphasized the importance of the Foreign Affairs Committee and expressed his confidence in the ability of Senator Siddiqui to provide strategic and insightful leadership. Ishaq Dar said that under Senator Irfan Siddiqui's guidance, the Ministry of Foreign Affairs will be well-equipped to navigate and address intricate global issues effectively. Source: Radio Pakistan